Posted by Michael Wonder on 02 Sep 2019
NHS saves more than £700 million on medicines costs
2 September 2019 - The NHS has announced that it has saved more than £700 million from the annual medicines bill to reinvest in new treatments, as part of the Long Term Plan.
The money comes from an NHS-wide campaign, which supported patients and doctors to maximise the use of ‘generic’ and best value ‘biologic’ treatments to treat conditions including arthritis and cancer.
NHS England has previously announced plans to accelerate and widen the uptake of best value biologic medicines in a bid to save £400 million to £500 million per year by 2020/21, as the money can then be be reinvested in other ‘new, innovative and cost-effective treatments.’
